Drug Shortage Report for APO-RASAGILINE
| Report ID | 76743 |
| Drug Identification Number | 02404699 |
| Brand name | APO-RASAGILINE |
| Common or Proper name | RASAGILINE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RASAGILINE |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 BTL |
| ATC code | N04BD |
| ATC description | DOPAMINERGIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-02-20 |
| Estimated end date | 2019-10-04 |
| Actual end date | 2019-08-28 |
| Shortage status | Resolved |
| Updated date | 2019-08-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2019-08-30 | French | Compare |
| v7 | 2019-08-30 | English | Compare |
| v6 | 2019-07-12 | French | Compare |
| v5 | 2019-07-12 | English | Compare |
| v4 | 2019-04-29 | French | Compare |
| v3 | 2019-04-29 | English | Compare |
| v2 | 2019-02-24 | French | Compare |
| v1 | 2019-02-24 | English | Compare |
Showing 1 to 8 of 8